triheptanoin
Sign in to saveTriheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
Key facts
- Drug.image
- Triheptanoin.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200
- Drug.alt
- Skeletal formula of triheptanoin
- Drug.image2
- Triheptanoin 3D spacefill.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 240
- Drug.alt2
- Space-filling model of the triheptanoin molecule
- Drug.tradename
- Dojolvi
- Drug.DailyMedID
- Triheptanoin
- Drug.routes_of_administration
- By mouth
- Drug.class
- Glycerolipids
- Drug.ATC_prefix
- A16
- Drug.ATC_suffix
- AX17
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.CAS_number
- 620-67-7
- Drug.PubChem
- 69286
via Wikipedia infobox
~3 min read
Encyclopedic overview
7 sectionsContents
- Medical uses
- History
- Names
- See also
- References
- Further reading
- External links
Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea.
Excerpted from Wikipedia’s “triheptanoin” article, available under the CC BY-SA 4.0 licence.